Prot #CCP-020-302: An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/20/17 → 11/20/20

Funding

  • Medpace Clinical Research LLC (Prot #CCP-020-302)
  • Castle Creek Pharmaceuticals LLC (Prot #CCP-020-302)